Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Sains dan Praktis Borobudur Pharmacy Review Borneo Journal of Pharmacy
Kartikawati, Nurfina Dian
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Digitalisasi Sebagai Upaya Peningkatan Kepatuhan Penggunaan Obat Pasien Tuberkulosis: Studi Literatur Kartikawati, Nurfina Dian; Febriani, Anisa Putri; Rizki, Rahmania Hafidhotur; Sari, Lutfiana
Borobudur Pharmacy Review Vol 4 No 2 (2024): August-Dec
Publisher : Universitas Muhammadiyah Magelang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31603/bphr.v4i2.12745

Abstract

Patient adherence to TB treatment regimen is essential to ensure recovery and prevent drug resistance. The use of drug reminder applications in the management of Tuberculosis (TB) is increasingly growing in the digital era. This literature aims to review the effect of drug reminder applications on TB patient adherence. The method used is a systematic literature review by searching various relevant scientific databases, such as Crossref and Google Scholar, for articles published in the last two years. The keywords in this study are: Tuberculosis; Drug Adherence; Drug Reminder Application. The literature search was conducted by combining Boolean search terms ("AND", "OR"). In 6 articles, the results of the literature showed that the use of drug reminder applications has a positive impact on patient adherence, with several studies showing an increase in adherence of up to 30%. Factors such as ease of use, daily reminder features, and support from health workers determine the success of the application. The main conclusion of this study is that digitalization of drug reminder applications has the potential to be an effective solution in improving TB patient adherence, but further research is needed to evaluate the sustainability of its impact in the long term.
PRINCIPLES OF DOSE ADJUSTMENT IN PATIENTS WITH CHRONIC KIDNEY FAILURE Mende, Juniarto; Kartikawati, Nurfina Dian; Titami, Arina; Mahmuda, Hartati
Jurnal Farmasi Sains dan Praktis Vol 11 No 2 (May-August 2025)
Publisher : Universitas Muhammadiyah Magelang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31603/pharmacy.v11i2.9687

Abstract

Chronic renal disease is a kidney illness marked by a progressive decline in kidney function over months or years. The usage of medications in this condition is a crucial aspect of managing kidney disease patients. When done correctly, pharmacotherapy can halt disease development and minimize morbidity and mortality. In patients with kidney illness, decreasing kidney function can drastically change the pharmacokinetics and pharmacodynamics of many medications, increase the risk of drug toxicity if not well treat. Many of these changes must be expected and mitigated by changing the medicine dosage. Complications of chronic kidney disease (CKD) that go untreated can cause significant early morbidity and mortality, as well as aggravate its progression. This literature review is based on a review of the literature and articles related to CKD to determine the principles of dose adjustment in CKD patients. Classification of drugs in CKD patients includes antifungals, anticoagulants, antidiabetics, antihypertensives, antibiotics, and analgesics. The administration of these drugs should be considered for kidney function in CKD patients. The presence of multidisciplinary interventions reduces the risk of progression of CKD severity. Adjustment of the dosage regimen in CKD patients is carried out for certain drugs that have a significant relationship between drug concentration and clinical outcomes in patients.
Interventions on Costs and Survival Rates of Lung Cancer Patients Yuliastuti, Fitriana; Kartikawati, Nurfina Dian; Pradani, Missya Putri Kurnia; Bunga, Cut Dewi; Mahato, Roshan Kumar
Borneo Journal of Pharmacy Vol. 8 No. 4 (2025): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v8i4.10049

Abstract

Lung cancer is characterized by the uncontrolled growth of cells in lung tissue, particularly in the respiratory tract lining. The disease has a high and alarming mortality rate, requiring prompt and appropriate management. This study aims to examine the costs and one-year survival rates of lung cancer patients at Dharmais Cancer Hospital. Data analysis was conducted in four stages: retrospective observational study using secondary data from medical records, describing patient characteristics and factors affecting survival and treatment costs, analyzing survival curves by cancer stage and intervention, and testing differences in survival curves using the log-rank test. The results show that higher survival rates are often inversely proportional to shorter survival times, and vice versa. Stage 1 patients exhibited the most extended survival despite low survival rates for inpatients (48 months, 25%) and outpatients (53 months, 15%). Intervention types 4.00 (chemotherapy and radiotherapy) and 7.00 (chemotherapy, radiotherapy, and surgery) effectively extended survival, although associated survival rates remained low. The highest inpatient treatment costs were observed in stage 2 patients, while the highest annual outpatient costs were linked to surgical interventions, highlighting the difference between per-episode and cumulative annual expenditures.
Co-Authors Bunga, Cut Dewi Febriani, Anisa Putri Fitriana Yuliastuti Juniarto Mende Mahato, Roshan Kumar Mahmuda, Hartati Pradani, Missya Putri Kurnia Rizki, Rahmania Hafidhotur Sari, Lutfiana Titami, Arina